Literature DB >> 9287984

The cystic fibrosis transmembrane conductance regulator as a marker of human pancreatic duct development.

K Hyde1, C J Reid, S J Tebbutt, L Weide, M A Hollingsworth, A Harris.   

Abstract

BACKGROUND & AIMS: The cystic fibrosis transmembrane conductance regulator (CFTR) protein is a small conductance adenosine 3',5'-cyclic monophosphate (cAMP)-activated chloride ion channel found in the apical membranes of epithelia within the pancreas, airway, intestine, bile duct, sweat gland, and male genital ducts. Pancreatic insufficiency is a feature of about 85% of patients with cystic fibrosis and is believed to be caused by pancreatic autolysis after pancreatic duct obstruction. The aim of this study was to investigate the expression of CFTR in the pancreas from early development to postnatal life to establish whether the CFTR plays a key role in development of the pancreatic duct epithelium.
METHODS: Expression of CFTR from the start of the mid-trimester of human development through term to adult life by messenger RNA (mRNA) in situ hybridization was examined.
RESULTS: CFTR mRNA is detected throughout the pancreatic duct epithelium and its pattern of expression follows the differentiation of the duct system.
CONCLUSIONS: CFTR is a valuable marker of human pancreatic duct cell development and differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9287984     DOI: 10.1016/s0016-5085(97)70187-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  13 in total

1.  Pancreatic bicarbonate secretion involves two proton pumps.

Authors:  Ivana Novak; Jing Wang; Katrine L Henriksen; Kristian A Haanes; Simon Krabbe; Roland Nitschke; Susanne E Hede
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

2.  Synchronous primary epithelial tumors of the pancreas.

Authors:  Nikolaos P Karidis; Panoraia Paraskeva; Dimitrios Mantas
Journal:  Int J Surg Case Rep       Date:  2012-05-25

3.  In vivo analysis of DNase I hypersensitive sites in the human CFTR gene.

Authors:  D S Moulin; A L Manson; H N Nuthall; D J Smith; C Huxley; A Harris
Journal:  Mol Med       Date:  1999-04       Impact factor: 6.354

4.  Genetic variation in CFTR and modifier loci may modulate cystic fibrosis disease severity.

Authors:  Alekh Paranjapye; Manon Ruffin; Ann Harris; Harriet Corvol
Journal:  J Cyst Fibros       Date:  2019-11-14       Impact factor: 5.482

5.  Krüppel-Like Factor 5 Regulates CFTR Expression Through Repression by Maintaining Chromatin Architecture Coupled with Direct Enhancer Activation.

Authors:  Alekh Paranjapye; Monali NandyMazumdar; Ann Harris
Journal:  J Mol Biol       Date:  2022-03-24       Impact factor: 6.151

6.  Rat pancreas secretes particulate ecto-nucleotidase CD39.

Authors:  Christiane E Sørensen; Jan Amstrup; Hans N Rasmussen; Ieva Ankorina-Stark; Ivana Novak
Journal:  J Physiol       Date:  2003-06-27       Impact factor: 5.182

Review 7.  The cystic fibrosis of exocrine pancreas.

Authors:  Michael Wilschanski; Ivana Novak
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

Review 8.  Human Molecular Genetics and the long road to treating cystic fibrosis.

Authors:  Ann Harris
Journal:  Hum Mol Genet       Date:  2021-10-01       Impact factor: 5.121

9.  Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency.

Authors:  N Peretti; V Marcil; E Drouin; E Levy
Journal:  Nutr Metab (Lond)       Date:  2005-05-03       Impact factor: 4.169

10.  A complex intronic enhancer regulates expression of the CFTR gene by direct interaction with the promoter.

Authors:  Christopher J Ott; Magdalena Suszko; Neil P Blackledge; Jane E Wright; Gregory E Crawford; Ann Harris
Journal:  J Cell Mol Med       Date:  2009-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.